Global Live Vaccines Market Forecast 2020-2030

1. Report Overview

1.1 Why You Should Read This Report

1.2 How This Report Delivers

1.3 Key Questions Answered by This Analytical Report:

1.4 Who is This Report for?

1.5 Methodology

1.5.1 Primary Research

1.5.2 Secondary Research

1.5.3 Market Evaluation & Forecasting Methodology

1.6 Frequently Asked Questions

1.7 Associated Reports

1.8 About Visiongain

2. Introduction to Live Vaccines

2.1 What are Live Vaccines?

2.2 Pros and Cons of Live, Attenuated Vaccines

2.3 WHO recommended vaccines using LAV Technology

2.4 Current Status of Vaccine Development

2.5 Role of Federal Agencies

2.6 Drug Development and Approval Process

2.7 Social and Economic Burden

3. Market Overview

3.1 Market Structure

3.2 Classification by Type

3.2.1 Bacterial

3.2.2 Viral

3.3 Classification by Indication

3.3.1 Oral Polio Vaccine (OPV)

3.3.2 Measles

3.3.3 Rotavirus

3.3.4 Tuberculosis

3.3.5 Yellow Fever

3.3.6 Others

3.4 Classification by Route of Administration

3.4.1 Oral

3.4.2 Injectable

3.5 Classification by End Users

4. Global Live Vaccines Market, 2020-2030

4.1 Global Live Vaccines Market, 2019

4.2 Global Live Vaccines Market Forecast, 2020-2030

4.3 Global Live Vaccines by Type

4.3.1 Global Live Vaccines by Type: Market Forecasts 2020-2030

4.4 Global Live Vaccines by Indication

4.4.1 Global Live Vaccines by Indication: Market Forecasts 2020-2030

4.5 Global Live Vaccines by Route of Administration

4.5.1 Global Live Vaccines by Route of Administration: Market Forecasts 2020-2030

4.6 Global Live Vaccines by End User

4.6.1 Global Live Vaccines by End User: Market Forecasts 2020-2030

5. Leading National Markets Forecast 2020-2030

5.1 Geographical Breakdown of Global Live Vaccines Market, 2019

5.1.1 Regional Breakdown of Global Live Vaccines Market, 2019

5.1.2 Country Breakdown of Global Live Vaccines Market, 2020

5.2 Regional Forecast of Global Live Vaccines Market, 2019-2030

5.3 North America Live Vaccines Market, 2020-2030

5.3.1 U.S. Live Vaccines Market Forecast, 2020-2030

5.3.2 Canada Live Vaccines Market Forecast, 2020-2030

5.4 Europe Live Vaccines Market, 2020-2030

5.4.1 Germany Live Vaccines Market Forecast, 2020-2030

5.4.2 France Live Vaccines Market Forecast, 2020-2030

5.4.3 UK Live Vaccines Market Forecast, 2020-2030

5.4.4 Italy Live Vaccines Market Forecast, 2020-2030

5.4.5 Spain Live Vaccines Market Forecast, 2020-2030

5.5.6 Rest of Europe Live Vaccines Market Forecast, 2020-2030

5.5 Asia Pacific Live Vaccines Market, 2020-2030

5.5.1 Japan Live Vaccines Market Forecast, 2020-2030

5.5.2 China Live Vaccines Market Forecast, 2020-2030

5.5.3 India Live Vaccines Market Forecast, 2020-2030

5.5.4 Rest of APAC Live Vaccines Market Forecast, 2020-2030

5.6 Latin America Live Vaccines Market, 2020-2030

5.6.1 Brazil Live Vaccines Market Forecast, 2020-2030

5.6.2 Mexico Live Vaccines Market Forecast, 2020-2030

5.6.3 Rest of Latin America Live Vaccines Market Forecast, 2020-2030

5.7 MEA Live Vaccines Market, 2020-2030

5.7.1 GCC Countries Live Vaccines Market Forecast, 2020-2030

5.7.2 South Africa Live Vaccines Market Forecast, 2020-2030

5.7.3 Rest of MEA Live Vaccines Market Forecast, 2020-2030

6. Qualitative Analysis of the Global Live Vaccines Market

6.1 SWOT Analysis of Global Live Vaccines Market

6.1.1 Strengths

6.1.2 Weakness

6.1.3 Opportunities

6.1.4 Threats

6.2 PEST Analysis

6.3 Market Trends

6.4 Market Drivers

6.4.1 Growing investment in vaccine development

6.4.2 High prevalence of infectious diseases

6.4.3 Rising Research and Development Activities

6.4.4 Increase in Government Focus on Immunization Programs

6.5 Market Restraints

6.5.1 Inadequate Reimbursement Coverage

6.5.2 Longer timelines required for Vaccine Production

6.5.3 Stringent Government Regulations for the Approval of Products

6.6 Market Challenges

6.6.1 Inadequate Access to Vaccines

6.6.2 Product Recalls

6.7 Market Opportunities

6.7.1 Growing demand from emerging economies

7. Leading Companies in Global Live Vaccines Market, 2020

7.1 Sanofi

7.2 Emergent BioSolutions Inc.

7.3 GlaxoSmithKline plc

7.4 Pfizer Inc.

7.5 Merck & Co., Inc.

7.6 DAIICHI SANKYO COMPANY, LIMITED

7.7 Inovio Pharmaceuticals, Inc.

7.8 Serum Institute of India

7.9 Bavarian Nordic

7.10 Mitsubishi Tanabe Pharma Corporation

7.11 AstraZeneca

7.12 Vivaldi Biosciences Inc.

8. Conclusions

9. Glossary

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain report evaluation form

List of Tables

Table 4.1 Global Live Vaccines Market by Sub-Markets: Revenue ($m), and Market Share (%), 2019

Table 4.2 Global Live Vaccines Market Forecast 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 4.3 Global Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 4.4 Global Live Vaccines Market by Type 2020-2030: AGR (%)

Table 4.5 Global Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 4.6 Global Live Vaccines Market by Indication 2020-2030: AGR (%)

Table 4.7 Global Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 4.8 Global Live Vaccines Market by Type 2020-2030: AGR (%)

Table 4.9 Global Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 4.10 Global Live Vaccines Market by End User 2020-2030: AGR (%)

Table 5.1 Global Live Vaccines Market by Region: Revenue ($m), and Market Share (%), 2019

Table 5.2 Global Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019

Table 5.3 Global Live Vaccines Market Forecast by Region, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.4 North America Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019

Table 5.5 North America Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.6 North America Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.7 North America Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.8 North America Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.9 U.S. Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.10 U.S. Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.11 U.S. Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.12 U.S. Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.13 Canada Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.14 Canada Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.15 Canada Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.16 Canada Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.17 Europe Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019

Table 5.18 Europe Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.19 Europe Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.20 Europe Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.21 Europe Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.22 Germany Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.23 Germany Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.24 Germany Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.25 Germany Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.26 France Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.27 France Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.28 France Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.29 France Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.30 UK Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.31 UK Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.32 UK Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.33 UK Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.34 Italy Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.35 Italy Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.36 Italy Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.37 Italy Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.38 Spain Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.39 Spain Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.40 Spain Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.41 Spain Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.42 Rest of Europe Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.43 Rest of Europe Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.44 Rest of Europe Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.45 Rest of Europe Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.46 Asia Pacific Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019

Table 5.47 Asia Pacific Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.48 Asia Pacific Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.49 Asia Pacific Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.50 Asia Pacific Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.51 Japan Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.52 Japan Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.53 Japan Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.54 Japan Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.55 China Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.56 China Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.57 China Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.58 China Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.59 India Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.60 India Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.61 India Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.62 India Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.63 Rest of APAC Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.64 Rest of APAC Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.65 Rest of APAC Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), CAGR (%)

Table 5.66 Rest of APAC Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), CAGR (%)

Table 5.67 Latin America Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019

Table 5.68 Latin America Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.69 Latin America Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.70 Latin America Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.71 Latin America Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.72 Brazil Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.73 Brazil Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.74 Brazil Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.75 Brazil Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.76 Mexico Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.77 Mexico Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.78 Mexico Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.79 Mexico Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.80 Rest of Latin America Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.81 Rest of Latin America Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.82 Rest of Latin America Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR(%), CAGR (%)

Table 5.83 Rest of Latin America Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.84 MEA Live Vaccines Market by Country: Revenue ($m), and Market Share (%), 2019

Table 5.85 MEA Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.86 MEA Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.87 MEA Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.88 MEA Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.89 GCC Countries Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.90 GCC Countries Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.91 GCC Countries Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.92 GCC Countries Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.93 South Africa Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.94 South Africa Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.95 South Africa Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.96 South Africa Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.97 Rest of MEA Live Vaccines Market Forecast by Type, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.98 Rest of MEA Live Vaccines Market Forecast by Indication, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.99 Rest of MEA Live Vaccines Market Forecast by Route of Administration, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 5.100 Rest of MEA Live Vaccines Market Forecast by End User, 2019-2030: Revenue ($m), AGR (%), CAGR (%)

Table 7.1 Company: Snapshot

Table 7.2: Product/Pipeline

Table 7.3: Product/Pipeline

Table 7.4 Company: Snapshot

Table 7.5: Product/Pipeline

Table 7.6: Recent Developments

Table 7.7 Company: Snapshot

Table 7.8: Product/Pipeline

Table 7.9 Company: Snapshot

Table 7.10: Product/Pipeline

Table 7.11 Company: Snapshot

Table 7.12: Product/Pipeline

Table 7.13 Company: Snapshot

Table 7.14: Product/Pipeline

Table 7.15 Company: Snapshot

Table 7.16: Product/Pipeline

Table 7.17: Recent Developments

Table 7.18 Company: Snapshot

Table 7.19: Product/Pipeline

Table 7.20 Company: Snapshot

Table 7.21: Product/Pipeline

Table 7.22: Recent Developments

Table 7.23 Company: Snapshot

Table 7.24: Product/Pipeline

Table 7.25 Company: Snapshot

Table 7.26 Company: Product/Pipeline

Table 7.27 Company: Snapshot

Table 7.28: Product/Pipeline

List of Figures

Figure 2.1 Vaccine Types, WHO

Figure 3.1 Global Live Vaccines Market Segmentation Overview

Figure 3.2 Live Vaccines Classification by Type, 2020

Figure 3.3 Bacterial Market, 2019-2030 (Revenue: $mn)

Figure 3.4 Medical conditions associated with viral vaccines

Figure 3.5 Viral Market, 2019-2030 (Revenue: $mn)

Figure 3.6 Live Vaccines Classification by Indication, 2020

Figure 3.7 Global Vaccination Coverage, 1980-2018

Figure 3.8 Global Vaccination Coverage, 2010-2018

Figure 3.9 Global Vaccination Coverage, 2018

Figure 3.10 Deaths Caused by Vaccine-Preventable Diseases Globally, 2017

Figure 3.11 Supply History and Breakdown of OPV Vaccines and WAP Trend

Figure 3.12 OPV Market, 2019-2030 (Revenue: $mn)

Figure 3.13 Measles Market, 2019-2030 (Revenue: $mn)

Figure 3.14 Rotavirus Market, 2019-2030 (Revenue: $mn)

Figure 3.15 Share of One-Year-Olds Vaccinated Against Rotavirus

Figure 3.16 Tuberculosis Market, 2019-2030 (Revenue: $mn)

Figure 3.17 Yellow Fever Market, 2019-2030 (Revenue: $mn)

Figure 3.18 Others Market, 2019-2030 (Revenue: $mn)

Figure 3.19 Live Vaccines Classification by Route of Administration, 2020

Figure 3.20 Global Live Vaccines Market by Route of Administration, 2019-2030 (Revenue: $mn)

Figure 3.21 Oral Market, 2019-2030 (Revenue: $mn)

Figure 3.22 Injectable Market, 2019-2030 (Revenue: $mn)

Figure 3.23 Live Vaccines Classification by End Users, 2020

Figure 3.24 Global Live Vaccines Market by End Users, 2019-2030 (Revenue: $mn)

Figure 4.1 Global Live Vaccines Market by Type: Market Share (%), 2019

Figure 4.2 Global Live Vaccines Market by Indication: Market Share (%), 2019

Figure 4.3 Global Live Vaccines Market by Route of Administration: Market Share (%), 2019

Figure 4.4 Global Live Vaccines Market by End User: Market Share (%), 2019

Figure 4.5 Global Live Vaccines Market by Region: Market Share (%), 2019

Figure 4.6 Global Live Vaccines Market Forecast 2019-2030: Revenue ($m), AGR (%)

Figure 4.7 Global Live Vaccines Market by Type: Market Share (%), 2020

Figure 4.8 Global Live Vaccines Market by Type: Market Share (%), 2025

Figure 4.9 Global Live Vaccines Market by Type: Market Share (%), 2030

Figure 4.10 Global Live Vaccines Market by Indication: Market Share (%), 2020

Figure 4.11 Global Live Vaccines Market by Indication: Market Share (%), 2025

Figure 4.12 Global Live Vaccines Market by Indication: Market Share (%), 2030

Figure 4.13 Global Live Vaccines Market by Route of Administration: Market Share (%), 2020

Figure 4.14 Global Live Vaccines Market by Route of Administration: Market Share (%), 2025

Figure 4.15 Global Live Vaccines Market by Route of Administration: Market Share (%), 2030

Figure 4.16 Global Live Vaccines Market by End User: Market Share (%), 2020

Figure 4.17 Global Live Vaccines Market by End User: Market Share (%), 2025

Figure 4.18 Global Live Vaccines Market by End User: Market Share (%), 2030

Figure 5.1 Global Live Vaccines Market Segmentation by Region/Country

Figure 5.2 Global Live Vaccines Market by Country: Market Share (%), 2020

Figure 5.3 Global Live Vaccines Market by Country: Market Share (%), 2025

Figure 5.4 Global Live Vaccines Market by Country: Market Share (%), 2030

Figure 5.5 North America Live Vaccines Market by Country: Market Share (%), 2020

Figure 5.6 North America Live Vaccines Market by Country: Market Share (%), 2025

Figure 5.7 North America Live Vaccines Market by Country: Market Share (%), 2030

Figure 5.8 Europe Live Vaccines Market by Country: Market Share (%), 2020

Figure 5.9 Europe Live Vaccines Market by Country: Market Share (%), 2025

Figure 5.10 Europe Live Vaccines Market by Country: Market Share (%), 2030

Figure 5.11 Asia Pacific Live Vaccines Market by Country: Market Share (%), 2020

Figure 5.12 Asia Pacific Live Vaccines Market by Country: Market Share (%), 2025

Figure 5.13 Asia Pacific Live Vaccines Market by Country: Market Share (%), 2030

Figure 5.14 Latin America Live Vaccines Market by Country: Market Share (%), 2020

Figure 5.15 Latin America Live Vaccines Market by Country: Market Share (%), 2025

Figure 5.16 Latin America Live Vaccines Market by Country: Market Share (%), 2030

Figure 5.17 MEA Live Vaccines Market by Country: Market Share (%), 2020

Figure 5.18 MEA Live Vaccines Market by Country: Market Share (%), 2025

Figure 5.19 MEA Live Vaccines Market by Country: Market Share (%), 2030

Figure 6.1 SWOT Analysis of the Global Live Vaccines Market

Figure 6.2 PEST Analysis of the Global Live Vaccines Market

Figure 6.3 Market Trends Analysis of the Global Live Vaccines Market